Several recent studies have suggested that expanded CAG repeats may contribute to the genetic transmission of bipolar disorder and schizophrenia. In all known disorders associated with expanded CAG repeats, the repeat sequence is translated into glutamine. Therefore the simplest hypothesis is that one or more proteins with expanded polyglutamine sequences are involved in the pathogenesis of bipolar disorder and schizophrenia. In order to examine this hypothesis, we have used an antibody against expanded polyglutamine sequences to examine Western blots prepared from lymphoblastoid cell lines of patients with schizophrenia and bipolar disorder. We also examined Western blots prepared from left frontal cortex tissue samples obtained from 11 schizophrenics post mortem. With the exception of the TATAbinding protein (TBP), we did not detect any proteins containing expanded polyglutamine sequences. Our data therefore suggest either that the expanded repeats which are associated with these disorders do not encode polyglutamine, or that they are within genes that are not expressed within the tissues investigated here.
Introduction
another group has obtained similar results for schizophrenia but not bipolar disorder. 13 Although it is well established that genes are major In all known diseases attributable to expanded CAG contributors to susceptibility in schizophrenia and repeats, CAG is translated into glutamine. Therefore bipolar disorder, the exact mode of inheritance of these the simplest hypothesis is that there is a protein (or disorders remains unknown.
1 However, there have proteins) involved in the pathogenesis of the functional been several recent reports of apparent anticipation in psychoses which contains expanded polyglutamine both conditions 2-7 consistent with the hypothesis of sequences. We have now examined this hypothesis by transmission of the major functional psychoses at least using a monoclonal antibody (mab1c2) to probe Westin part through an expanded trinucleotide repeat ern blots prepared from lymphoblastoid cell lines of mechanism. However, since these studies have been patients with schizophrenia and bipolar disorder, and conducted in families originally ascertained for genetic from post-mortem frontal cortex of schizophrenics. linkage analysis, they are almost inevitably biased mab1c2 was originally raised against peptides overlaptowards finding earlier ages of onset in younger generping the polyglutamine stretch of the TATA-binding ations. 8 Since this bias simulates anticipation, it is as protein (TBP) but has been found to recognise large yet premature to conclude that true genetic anticipolyglutamine sequences in general.
14 pation occurs in schizophrenia and bipolar disorder. Nevertheless, the hypothesis that an expanded trinucleotide repeat mechanism is involved in the pathogenMaterials and methods esis of schizophrenia and bipolar disorder has recently Cell lines received support from a series of studies which have Lymphoblastoid cell lines were previously established reported that the average maximum CAG/CTG repeat at the European Collection of Animal Cell Cultures at size is greater in patients with either disorder than it Porton Down from patients with either DSMIII-R 15 is in controls. [9] [10] [11] These findings have now been further bipolar disorder or schizophrenia. Diagnoses were replicated in a large multi-centre European study 12 and made using a standardised interview and all available clinical material as previously described. 12 Cell lines were retrieved from individuals (schizophrenia: n = 18, 8 male, 10 female, mean age 50, mean age onset 26 (s.d. determined to have maximum CAG/CTG repeat expan-sion detection products of more than 50 repeats in a Apart from TBP, many of the lanes revealed a variable faint immunoreactive doublet at around 100 kDa previous study. 12 Huntington's disease (HD, n = 2) and several neurofibromatosis and tubular sclerosis patientalthough this was present in controls as well as patients. This doublet was more easily visualised by derived cell lines were used anonymously (n = 14). All cell lines were from UK Caucasians.
overexposure (data not shown) where it was seen as a band of rather variable size. Prolonged exposure (data Cells were pelleted, washed in phosphate-buffered saline (PBS) and solubilised in 0.1% SDS in PBS. Pronot shown) also revealed that there are other faintly immunoreactive proteins at around 200 kDa, 80 kDa tein concentration in each sample was determined using the method of Peterson. 16 and 30 kDa but these were equally present in controls as well as schizophrenic and bipolar probands.
Protein extracts from brain tissue from schizoBrain tissue Frozen brain tissue from 11 clinically diagnosed phrenics were also analysed, as this is the tissue in which an expanded repeat contributing to psychosis is schizophrenics (7 female, 4 male) was obtained from the MRC Alzheimer's disease brain bank at the Institute most likely to be expressed. published results obtained using other anti-huntingtin antibodies in similar tissue. 19 Only TBP immunoreacviduals who had died after a CVA. Samples of 1-2 g cortex were homogenised in 5 mM HEPES pH 7.4 with tivity is evident in the protein extracts from the brains of schizophrenics and controls. Complete Protease Inhibitor (Boehringer-Mannheim, Lewes, East Sussex, UK) using 12 strokes in a handheld glass-teflon homogeniser. Protein concentration Discussion was determined as above. This study was undertaken to test the hypothesis that there is a protein (or proteins) involved in the pathoWestern blotting Proteins were separated by SDS-PAGE on 4-15% gradigenesis of schizophrenia and bipolar disorder which contains an expanded polyglutamine sequence. Howent gels (Biorad, Hercules, CA, USA) as described, 17 then wet blotted for 10 h at 30 V onto a PVDF memever, with the exception of TBP we have failed to detect expanded polyglutamine sequences in lymphobrane 18 (Immobilon P, Millipore, Watford, Herts, UK). Blots were probed with 1/2000 1C2 monoclonal antiblastoid cell lines of bipolar and schizophrenic probands or in the post-mortem brains of patients with body 14 and were then developed using horseradish peroxidase-conjugated secondary antibodies and schizophrenia.
In these experiments, the internal control TBP can enhanced chemiluminescence (Amersham, Little Chalfont, Bucks, UK).
be seen clearly in all of our lymphoblastoid samples and although huntingtin is expressed at low levels in lymphoblastoid cell lines, 20 we were nevertheless able Results to clearly detect it. Therefore we would have expected to detect other proteins containing expanded CAG There was no evidence of any strongly immunoreactive band other than that of the TATA-binding protein repeats unless they were expressed at extremely low levels in the cell lines established from the schizo-(TBP) in the protein extracts of lymphoblastoid cell lines established from schizophrenic or bipolar prophrenic and bipolar probands. In brain, although there was considerable protein bands (Figure 1) . Although TBP immunoreactivity in each patient sample acts as an internal control for the degradation, we still obtained strong huntingtin immunoreactivity with the 1C2 antibody. This suggests that Western blotting procedure, we also blotted and probed protein extracts from cell lines derived from prowe would expect to detect immunoreactivity from expanded polyglutamine repeats in the brains of bands with HD (sizes of the huntingtin repeats in the first and second samples are 46/16 and 51/19 schizophrenics if it was present. It is therefore unlikely that our failure to detect proteins with expanded polyrespectively), as a further demonstration of the suitability of our procedures for detecting large polyglutaglutamine repeats in the tissues of schizophrenic and bipolar probands is a result of methodological probmine repeats (samples h, Figure 1 . Note that the HD and non-HD controls were run on different gels therelems in our Western blotting and probing procedures. In conditions such as schizophrenia and bipolar disfore the control molecular weight marker sizes given do not apply to the HD samples). Strong signals correorder which are presumed to be genetically heterogeneous, it is essential to consider the power of any sponding to expanded repeats in huntingtin are present in both lanes although it is apparent that the first sam-'negative' study as an explanation for the findings. We have examined cell line DNA from 18 bipolar and 18 ple has incompletely solubilised. schizophrenic probands. In an unselected sample of bipolar disorder but these may act as weak epitopes for the antibody which therefore binds poorly. For patients, this gives a power of 95% to detect an expanded repeat that is involved in the pathogenesis of example it appears that the binding of the antibody is not completely specific to the number of repeats. each disorder assuming 17% of patients carry a repeat related to disease susceptibility. In fact the power in Instead, it binds progressively less efficiently to shorter repeats 14 and this phenomenon may be responsible for this study is considerably greater than 95% as more than 17% of unselected psychotic probands are likely the faint signals in Figure 1 . Indeed an allele with 12 repeats was detected in an expression library with this to carry an expanded repeat related to the disorder 21 assuming our RED data are approximately correct. 12 antibody. 28 However, although rather small repeats have recently been determined as the cause of SCA 6, 29 Furthermore, the sample studied here was enriched for probands who were most likely to have expanded our RED data indicate that the repeat size of interest in schizophrenia and bipolar disorder is much larger, and repeats giving a power of more than 99%. 21 Therefore it is unlikely that lack of power was responsible for our is also larger than the repeats found in TBP and our HD controls. Since in our hands, the antibody can clearly negative findings. Our data therefore suggest that the repeats which are associated with schizophrenia and identify the polyglutamines in TBP and HD, and others have used it to detect the proteins that cause spinobipolar disorder do not encode large polyglutamine tracts. cerebellar ataxias 1, 2, 3 as well as several other putative CAG repeat diseases, 14 this is not a particularly One possible explanation for our data is that the association between these disorders and large convincing explanation for our data. We conclude then, bearing in mind the above CAG/CTG repeats is an artifact of stratification. 12 However, we would stress that our data do not address this caveats, that our data provide no support for the hypothesis that the expanded CAG repeat(s) which are possibility nor do they refute the hypothesis that CAG/CTG repeats contribute to the pathogenesis of associated with schizophrenia and bipolar disorder mediate a pathogenic effect through expansion of a schizophrenia and bipolar disorder. Even if they are not translated to polyglutamine, the CAG/CTG repeats polyglutamine tract. The absence of a pathogenic mechanism that is common to schizophrenia, bipolar associated with psychosis may exert an effect at the level of mRNA-protein interaction as some CAG disorder and the known expanded CAG repeat diseases perhaps should not come as a surprise as there are only repeats contained within mRNA bind proteins in a repeat number-dependent manner. 22 Alternatively, the weak parallels between the known expanded CAG repeat diseases and the functional psychoses. 8 For repeat may act by translation in the frames AGC, GCA, CTG, TGC or GCT, which encode threonine, alanine, example all known CAG repeat diseases are neurodegenerative which does not appear to be the case for leucine, cysteine and serine respectively, they may be located in untranslated parts of the gene as in myotonic either schizophrenia or bipolar disorder. Furthermore, schizophrenia and bipolar disorder display considerdystrophy 23 or they may be intronic and alter transcription like the GAA repeat in Friedreich's Ataxia. 24 ably more marked deviations from simple patterns of inheritance than, for example, HD which was preThere are, however, a number of other explanations for our data which must be considered. contribute to the pathogenesis of schizophrenia and
